T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Meritage Homes
MTH
$4.75B
| $136M | 0.03% |
5,582,100
-389,260
| -7% | -$7.87M |
|
527
NXP Semiconductors
NXPI
$58.9B
| $136M | 0.03% |
1,352,241
-362,874
| -21% | -$32M |
|
|
TMH
528
DELISTED
Team Health Holdings Inc
TMH
| $135M | 0.03% |
2,313,260
+11,716
| +0.5% | +$664K |
|
|
ELME
529
Elme Communities
ELME
$144M
| $135M | 0.03% |
4,889,640
+108,920
| +2% | +$3.08M |
|
530
Host Hotels & Resorts
HST
$15.6B
| $135M | 0.03% |
6,667,518
-716,097
| -10% | -$16M |
|
531
LyondellBasell Industries
LYB
$20.3B
| $134M | 0.03% |
1,522,986
-1,457,349
| -49% | -$123M |
|
532
Assured Guaranty
AGO
$3.29B
| $133M | 0.03% |
5,033,121
+19,260
| +0.4% | +$498K |
|
|
DCT
533
DELISTED
DCT Industrial Trust Inc.
DCT
| $133M | 0.03% |
3,831,599
-9,390
| -0.2% | -$339K |
|
534
Toronto Dominion Bank
TD
$204B
| $132M | 0.03% |
3,092,878
+1,742,325
| +129% | +$74.9M |
|
|
ESRX
535
DELISTED
Express Scripts Holding Company
ESRX
| $132M | 0.03% |
1,523,757
+17,786
| +1% | +$1.49M |
|
|
CIT
536
DELISTED
CIT Group Inc.
CIT
| $132M | 0.03% |
2,921,982
-1,779,205
| -38% | -$80.8M |
|
537
Alnylam Pharmaceuticals
ALNY
$30B
| $132M | 0.03% |
1,261,604
+19,578
| +2% | +$1.98M |
|
538
KBR
KBR
$4.8B
| $131M | 0.03% |
9,060,280
+1,208,940
| +15% | +$19.7M |
|
539
Prothena Corp
PRTA
$475M
| $131M | 0.03% |
3,439,296
+2,800
| +0.1% | +$71.8K |
|
540
American International
AIG
$39.8B
| $130M | 0.03% |
2,377,524
+20,610
| +0.9% | +$1.11M |
|
541
Middleby
MIDD
$5.38B
| $130M | 0.03% |
1,266,390
-83,933
| -6% | -$8.53M |
|
|
JBTM
542
JBT Marel
JBTM
$6.15B
| $129M | 0.03% |
3,618,105
+53,160
| +1% | +$1.76M |
|
543
Highwoods Properties
HIW
$3.46B
| $129M | 0.03% |
2,815,917
-8,420
| -0.3% | -$388K |
|
544
ESCO Technologies
ESE
$7.78B
| $128M | 0.03% |
3,287,030
-1,030
| -0% | -$38.6K |
|
545
Terreno Realty
TRNO
$7.48B
| $128M | 0.03% |
5,607,990
+220,570
| +4% | +$4.96M |
|
|
NATI
546
DELISTED
National Instruments Corp
NATI
| $128M | 0.03% |
3,984,085
-440,840
| -10% | -$13.7M |
|
|
QUOT
547
DELISTED
Quotient Technology Inc
QUOT
| $127M | 0.03% |
10,854,733
+1,108,465
| +11% | +$14.4M |
|
548
General Mills
GIS
$20.4B
| $127M | 0.03% |
2,249,041
-11,806
| -0.5% | -$630K |
|
549
MakeMyTrip
MMYT
$5.67B
| $126M | 0.03% |
5,758,014
+62,000
| +1% | +$1.51M |
|
550
Packaging Corp of America
PKG
$22.8B
| $126M | 0.03% |
1,613,519
-398,525
| -20% | -$31.6M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.